Comparison of treatment efficacy between adjuvant intravenous chemotherapy and intravenous chemotherapy combined with intraperitoneal perfusion chemotherapy to treat postresection colon cancer
Conclusion: After radical resection, patients who received IVC + IPC showed prolonged DFS than those received IVC, as well as fewer peritoneal metastasis. Compared to IPC, no significantly increased side effects or complications were occurred after IVC + IPC. More work should be performed to confirm that IVC + IPC was superior to IVC for treating postresection colon cancer.
Source: Journal of Cancer Research and Therapeutics - Category: Cancer & Oncology Authors: Tao Jiang Rui Feng Zhangchi Pan Qian Xu Wenyu Gao Sheng Yang Qiang Chen Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Colon Cancer | Colorectal Cancer | Perfusion | Study | Toxicology | Undifferentiated Carcinoma